Skip to content

The effect of dextrose and corticosteroid injections in CTS patients

Efficacy of neurofascial dextrose prolotherapy on pain and function of patients with carpal tunnel syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180416039323N3
Enrollment
44
Registered
2021-11-27
Start date
2021-12-16
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carpal tunnel syndrom.

Interventions

Intervention 1: Intervention group 1 Under one injection with 5 cc D5W inside the carpal tunnel of the wrist. Intervention 2: Intervention group 2 Injected with 1 cc of methylprednisolone and 0.5 cc

Sponsors

Artesh University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Nocturnal paresthesia / dysplasia with or without excessive pain on the hands Numbness In the sensory distribution of the median nerve Weakness with atrophic changes in the Median nerve innervated Positive Phalen or Tinel test Age 20 to 80 years They have mild to moderate CTS and their symptoms last for more than three months And have been resistant to drug therapy and splints conscious patient satisfaction

Exclusion criteria

Exclusion criteria: History of polyneuropathy History of inflammatory arthritis Current use of warfarin Previous steroid injection for CTS Trauma at the injection site Allergy to corticosteroid skin infection at the injection site neoplasm at the injection site History of Brachial plexiopathy History of thoracic outlet syndrome History of wrist surgery History of hypothyroidism History of pregnancy History of rheumatic disorders History of having a pacemaker

Design outcomes

Primary

MeasureTime frame
Intensity of pain. Timepoint: before intervention, 1 month after intervention, 3 months after intervention. Method of measurement: A 10-point VAS scale that the patient should give a score from 0 to 10.;Evaluation of patient performance with Boston questionnaire. Timepoint: before intervention, 1 month after intervention, 3 months after intervention. Method of measurement: Boston Questionnaire Score.;Electrodiagnostic criteria. Timepoint: before intervention, 1 month after intervention, 3 months after intervention. Method of measurement: Based on the latency duration and amp intensity in SNAP, CMAP median nerve, we determine the severity of involvement and recovery.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahimeh Tafti

Artesh University of Medical Sciences

fahimeh_tafti65@yahoo.com+98 21 8609 6350

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026